?Avacta Set to re-write science27 Jun 2020 16:37
A bold statement indeed – so for those here only for up coming world beating covid-19 tests and cure, I would recommend to also look at
https://en.m.wikipedia.org/wiki/Affimer
Alexander Fleming re-wrote science by pioneering a proactive way to fight most bodily illness by in effect injecting an invasion force (antibody) into the invaded body to assist the body in wagering war on the invader until victory, it was brilliant, a world beater and so-named Penicillin, and antibiotics / antibodies have been the standard way since 1923. Of course the only problem / side effect has always been the bodily energy, strength and damage used fighting and winning this war.
What Avacta have done is reinvent Medical science, their tailor make affimer molecules enter the body and instead of assisting it in waging a war against example the covid spike, cancer, Leukaemia, or example any future virus, they simply impersonate then enter the covid, or cancer cell / spore then neutralise it. In effect Affimer molecules are an injected peace keeping force / high level negotiator entering the body to simply neutralise the war, the end product neither side wins - but great thing is the body, or grounds possessed quickly emerge without battle damage - now that to me and many others is magic !
This is the reason Avacta have JV’s with US majors like Cytiva (formerly GE) and Adeptrix and most importantly they have patented the Affimers and have the Licences - this isn’t pie in the sky jam tomorrow stuff.
In the short term the tests will generate massive income and orders hence the reason Some of the Boo Hoo boys have set up medusa19.com to make a fortune selling it on.
This world changing science has been 6 years in the making – if it’s just the covid-19 tests and cures that once completed with billions of confirmed worldwide orders spiking the SP to £5 maybe even £10 in the next few months fine - it’s a great trade and I’m 90% a trader too.
But for the majority the focus is way beyond the current £100 billion Cancer Leukaemia market
DYOR and best wishes